Objective: Inelaborate use of new quinolones with strong anti-tuberculosis (TB) activity leads to difficulty in diagnosis and more importantly, quinolone-resistant Mycobacterium tuberculosis. We aimed to determine the frequency of quinolone use in patients who were referred to our hospital for suspected TB and to evaluate the association between quinolone use and different clinical laboratory parameters. Methods: Between November 15 and December 15, 2013, all patients who were admitted to the TB outpatient clinic with no previous diagnosis of TB were included in this study. Demographic and clinical laboratory findings and history of antibiotic use were recorded. Patients' quinolone use were questioned by showing fluoroquinolone antibiotic b...
The fluoroquinolones have secured an important place in the management of bacterial infection, they ...
INTRODUCTION: Global multidrug-resistant tuberculosis (MDR-TB) treatment success rates remain subopt...
Currently the World Health Organization only recommend fluoroquinolones for people with presumed dru...
Objective: Inelaborate use of new quinolones with strong anti-tuberculosis (TB) activity leads to di...
OBJECTIVES: Fluoroquinolones are used in second-line treatment of tuberculosis (TB) and have a poten...
Setting. Tuberculosis treatment requires long regimens with multiple antibiotics and is complicated ...
Setting. Tuberculosis treatment requires long regimens with multiple antibiotics and is complicated ...
OBJECTIVE: The excellent in vitro activity of fluoroquinolones against Mycobacterium tuberculosis ha...
WOS: 000435396300005PubMed ID: 30020039Introduction: Increased tuberculosis prevalence, and isolatio...
Tuberculosis (TB) remains a major public health concern, and a delay in its diagnosis leads to conti...
OBJECTIVES: Fluoroquinolones have a potential role in shortening tuberculosis (TB) treatment duratio...
Objectives: Fluoroquinolones have a potential role in shortening tuberculosis (TB) treatment duratio...
The use of fluoroquinolones (FQs) to treat lower respiratory tract infections (LTRI) other than tube...
SETTING: Systematic studies of fluoroquinolones (FQs) and Clostridium difficile-associated diarrhoea...
Fluoroquinolone is recommended as a pivotal antituberculous agent for treating multi-drug-resistant ...
The fluoroquinolones have secured an important place in the management of bacterial infection, they ...
INTRODUCTION: Global multidrug-resistant tuberculosis (MDR-TB) treatment success rates remain subopt...
Currently the World Health Organization only recommend fluoroquinolones for people with presumed dru...
Objective: Inelaborate use of new quinolones with strong anti-tuberculosis (TB) activity leads to di...
OBJECTIVES: Fluoroquinolones are used in second-line treatment of tuberculosis (TB) and have a poten...
Setting. Tuberculosis treatment requires long regimens with multiple antibiotics and is complicated ...
Setting. Tuberculosis treatment requires long regimens with multiple antibiotics and is complicated ...
OBJECTIVE: The excellent in vitro activity of fluoroquinolones against Mycobacterium tuberculosis ha...
WOS: 000435396300005PubMed ID: 30020039Introduction: Increased tuberculosis prevalence, and isolatio...
Tuberculosis (TB) remains a major public health concern, and a delay in its diagnosis leads to conti...
OBJECTIVES: Fluoroquinolones have a potential role in shortening tuberculosis (TB) treatment duratio...
Objectives: Fluoroquinolones have a potential role in shortening tuberculosis (TB) treatment duratio...
The use of fluoroquinolones (FQs) to treat lower respiratory tract infections (LTRI) other than tube...
SETTING: Systematic studies of fluoroquinolones (FQs) and Clostridium difficile-associated diarrhoea...
Fluoroquinolone is recommended as a pivotal antituberculous agent for treating multi-drug-resistant ...
The fluoroquinolones have secured an important place in the management of bacterial infection, they ...
INTRODUCTION: Global multidrug-resistant tuberculosis (MDR-TB) treatment success rates remain subopt...
Currently the World Health Organization only recommend fluoroquinolones for people with presumed dru...